University of California, San Diego: Non-alcoholic Fatty Liver Disease trials
The registry lists 14 Non-alcoholic Fatty Liver Disease studies with University of California, San Diego as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 2 6No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)RecruitingNCT07518784
- Implementing Food Referrals for Equity and Sustained HealthRecruitingNCT06661538Phase 2
- Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyCompletedNCT02684591Phase 2Results posted
- Dietary Treatment Study of Pediatric NAFLDCompletedNCT02513121Not applicableResults posted
- Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseCompletedNCT01963845Phase 2Results posted
- Ezetimibe Versus Placebo in the Treatment of Non-alcoholic SteatohepatitisCompletedNCT01766713Phase 2Results posted
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisCompletedNCT01066364Phase 2Results posted
- Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab TherapyWithdrawnNCT07255781
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMActive, not recruitingNCT06005012Phase 2
- Accurate Point of Care Liver Disease DiagnosticsActive, not recruitingNCT05986916
- Treating Pediatric NAFLD with NutritionCompletedNCT05499585Not applicable
- Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes PatientsCompletedNCT04462081
- Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As ReferenceCompletedNCT04389593
- Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLDStatus unknownNCT02124577